ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

University of Milan at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

University of Milan takes part in 12 sessions at ESMO 2026 in Madrid. Its program spans breast cancer, blood cancers, lung cancer, and rare tumours, with attention to cancer care under resource constraints. Specific topics include treatment options for advanced breast cancer and prognostic assessment in myelofibrosis.

OrganizationESMO 2026 Attendance
University & institute
Public research university in Milan, Italy, with a faculty of medicine and surgery.
Poster
Fri Oct 23
13:00–15:00
Diagnostic management of cardiac masses and primary cardiac sarcoma (PCS): A nationwide Italian survey
ePoster session 20
Sarcoma, CNS, head & neck and rare cancers
Talk
Fri Oct 23
14:20–14:35
Pharmacology perspective
Invasive lobular carcinoma: Detecting and managing an elusive enemy
Breast cancer
Chair
Sat Oct 24
16:30–18:00
Updates on myeloid neoplasms with a focus on medical oncology practice
with MD Anderson Cancer Center
Haematological malignancies
Talk
Sat Oct 24
17:30–17:50
Prognostic assessment to guide treatment of myelofibrosis
Updates on myeloid neoplasms with a focus on medical oncology practice
Haematological malignancies
Poster
Sun Oct 25
12:00–12:45
Poster
Sun Oct 25
12:00–12:45
Chair
Sun Oct 25
14:45–16:15
Accessible cancer care for everyone, everywhere: Improving patient care globally
with Te Whatu Ora Capital, Coast and Hutt Valley
Talk
Sun Oct 25
15:30–15:45
Medicine shortages: ESMO’s role in the EU response and the Critical Medicines Alliance
Accessible cancer care for everyone, everywhere: Improving patient care globally
Chair
Mon Oct 26
10:15–11:45
When standards are unsustainable: Redefining cancer treatment under resource pressure
with Kenyatta University Teaching, Referral and Research Hospital
Talk
Mon Oct 26
11:22–11:37
Should adaptation be legitimised?
When standards are unsustainable: Redefining cancer treatment under resource pressure
Poster
Mon Oct 26
12:00–12:45
Clinical outcomes and molecular landscape of metastatic extrapulmonary neuroendocrine carcinomas (mEP-NEC) beyond first-line failure
Monday Poster Display session 2
Sarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology
Satellite
Mon Oct 26
18:45–19:00
Mechanism of action and differentiating characteristics of immune checkpoint inhibitors
Accord Healthcare - Navigating immunotherapy options in first-line ES-SCLC and NSCLC
Lung & thoracic cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Milan

Tell us what you sell and we’ll find the people at University of Milan most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction